Clinical Trials Browser

Completed × blinatumomab × 30 days × Clear all

NCT02997761 2026-04-07

Ibrutinib and Blinatumomab in Treating Patients With Relapsed or Refractory B Acute Lymphoblastic Leukemia

Phase 2 Completed

Burkitt Lymphoma